# Is in Vitro Maturation of Oocytes Influenced by the Origin of Gonadotropins Used in Maturation Medium: is There a Difference in Efficiency When Using Urinary Versus Recombinant Produced Follicle Stimulating Hormone and Human Chorionic Gonadotropin

> **NCT05370794** · — · UNKNOWN · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 35 (estimated)

## Conditions studied

- In Vitro Maturation of Oocytes

## Interventions

- **DRUG:** rhCG= Ovitrelle®, 250g/0.5ml = 26000IU/ml, Merck-Serono
- **DRUG:** rFSH = Gonal F®, 300IU/0.5ml, Merck-Serono

## Key facts

- **NCT ID:** NCT05370794
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-19
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2022-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05370794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05370794, "Is in Vitro Maturation of Oocytes Influenced by the Origin of Gonadotropins Used in Maturation Medium: is There a Difference in Efficiency When Using Urinary Versus Recombinant Produced Follicle Stimulating Hormone and Human Chorionic Gonadotropin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05370794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*